John R. Moore, VP, General Counsel at ARRAY BIOPHARMA INC (ARRY), sold 28,547 shares at $5.69 ($162K) on 2012-10-08, disclosed to the SEC on 2012-10-09.
Scheduled sale ($162k) by VP, General Counsel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.69 | 2,357 | $13K | 8.3% |
| 2 | $5.69 | 26,190 | $149K | 91.7% |
| Total | $5.69 avg | 28,547 | $162K | 100% |
| Filing → |
| EWTX | SELL | 2025-05-07 | $32K | — | Filing → |
| EWTX | SELL | 2024-09-24 | $2.6M | — | Filing → |
| EWTX | SELL | 2024-05-03 | $37K | — | Filing → |